165 related articles for article (PubMed ID: 8514448)
1. Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in Iceland, 1964-1991.
Sigurdsson K
Int J Cancer; 1993 Jun; 54(4):563-70. PubMed ID: 8514448
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of cervical cancer screening in Iceland, 1964-2002: a study on trends in incidence and mortality and the effect of risk factors.
Sigurdsson K; Sigvaldason H
Acta Obstet Gynecol Scand; 2006; 85(3):343-9. PubMed ID: 16553184
[TBL] [Abstract][Full Text] [Related]
3. Quality assurance in cervical cancer screening: the Icelandic experience 1964-1993.
Sigurdsson K
Eur J Cancer; 1995; 31A(5):728-34. PubMed ID: 7640046
[TBL] [Abstract][Full Text] [Related]
4. [The Nordic cervical screening programmes through 1995. Evaluation of incidence and mortality rates, targeted age groups and screening intervals.].
Sigurdsson K
Laeknabladid; 1999 Nov; 85(11):862-72. PubMed ID: 19439775
[TBL] [Abstract][Full Text] [Related]
5. Trends in cervical and breast cancer in Iceland. A statistical evaluation of trends in incidence and mortality for the period 1955-1989, their relation to screening and prediction to the year 2000.
Sigurdsson K; Adalsteinsson S; Ragnarsson J
Int J Cancer; 1991 Jun; 48(4):523-8. PubMed ID: 2045199
[TBL] [Abstract][Full Text] [Related]
6. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.
Sigurdsson K
Acta Obstet Gynecol Scand; 1999 Jul; 78(6):478-85. PubMed ID: 10376856
[TBL] [Abstract][Full Text] [Related]
7. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
[TBL] [Abstract][Full Text] [Related]
8. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
9. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
10. Effect of regular 3-yearly screening on the incidence of cervical smears: the Leiden experience.
Boon ME; de Graaff Guilloud JC; Rietveld WJ; Wijsman-Grootendorst A
Cytopathology; 1990; 1(4):201-10. PubMed ID: 2101670
[TBL] [Abstract][Full Text] [Related]
11. Screening as a prognostic factor in cervical cancer: analysis of survival and prognostic factors based on Icelandic population data, 1964-1988.
Sigurdsson K; Hrafnkelsson J; Geirsson G; Gudmundsson J; Salvarsdóttir A
Gynecol Oncol; 1991 Oct; 43(1):64-70. PubMed ID: 1959790
[TBL] [Abstract][Full Text] [Related]
12. Screening frequency and atypical cells and the prediction of cervical cancer risk.
Chen YY; You SL; Koong SL; Liu J; Chen CA; Chen CJ;
Obstet Gynecol; 2014 May; 123(5):1003-1011. PubMed ID: 24785853
[TBL] [Abstract][Full Text] [Related]
13. Trends in cancer of the cervix uteri in Sweden following cytological screening.
Bergström R; Sparén P; Adami HO
Br J Cancer; 1999 Sep; 81(1):159-66. PubMed ID: 10487628
[TBL] [Abstract][Full Text] [Related]
14. The changing pattern of cervical cancer in Northern Ireland 1965-1989.
Robertson JH; Woodend B
Ulster Med J; 1992 Apr; 61(1):19-23. PubMed ID: 1621297
[TBL] [Abstract][Full Text] [Related]
15. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
[TBL] [Abstract][Full Text] [Related]
17. Screening and adenocarcinoma of the cervix.
Sasieni P; Castanon A; Cuzick J
Int J Cancer; 2009 Aug; 125(3):525-9. PubMed ID: 19449379
[TBL] [Abstract][Full Text] [Related]
18. Implementing the national invasive cervical cancer audit: a local perspective.
Moss EL; Pearmain P; Askew S; Owen G; Reynolds TM; Prabakar IM; Douce G; Parkes J; Menon V; Todd RW; Redman CW
BJOG; 2010 Oct; 117(11):1411-6. PubMed ID: 20716252
[TBL] [Abstract][Full Text] [Related]
19. Advancing age and cervical cancer screening and prognosis.
Sawaya GF; Sung HY; Kearney KA; Miller M; Kinney W; Hiatt RA; Mandelblatt J
J Am Geriatr Soc; 2001 Nov; 49(11):1499-504. PubMed ID: 11890589
[TBL] [Abstract][Full Text] [Related]
20. Changes in cervical cancer incidence after three decades of screening US women less than 30 years old.
Chan PG; Sung HY; Sawaya GF
Obstet Gynecol; 2003 Oct; 102(4):765-73. PubMed ID: 14551007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
